Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis (2022)
Joaquim, Helena P. G; Costa, Alana C; Pereira, Cicero A. C; Talib, Leda L; Bilt, Martinus M. V; Loch, Alexandre A; Gattaz, Wagner Farid 
Source: European journal of neuroscience. Unidade: FM
Subjects: PSICOSE EM ADULTO, CANABINOIDES, PSICOSE INFANTIL, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G et al. Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis. European journal of neuroscience, v. 55, n. 4, p. 1079-1087, 2022Tradução . . Disponível em: https://doi.org/10.1111/ejn.15509. Acesso em: 28 abr. 2024.APA
Joaquim, H. P. G., Costa, A. C., Pereira, C. A. C., Talib, L. L., Bilt, M. M. V., Loch, A. A., & Gattaz, W. F. (2022). Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis. European journal of neuroscience, 55( 4), 1079-1087. doi:10.1111/ejn.15509NLM
Joaquim HPG, Costa AC, Pereira CAC, Talib LL, Bilt MMV, Loch AA, Gattaz WF. Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis [Internet]. European journal of neuroscience. 2022 ; 55( 4): 1079-1087.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1111/ejn.15509Vancouver
Joaquim HPG, Costa AC, Pereira CAC, Talib LL, Bilt MMV, Loch AA, Gattaz WF. Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis [Internet]. European journal of neuroscience. 2022 ; 55( 4): 1079-1087.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1111/ejn.15509
